Web2 days ago · Activist shareholder Carl Icahn, in the midst of a proxy battle with Illumina, is advocating for a spinoff of the company’s Grail cancer-detection business into a separate publicly traded entity and the return to a focus on its core DNA-sequencing business. WebSep 1, 2024 · September 1, 2024 A judge has ruled in favor of Illumina in its acquisition of Grail dealing a blow to the Us Federal Trade Commission’s efforts to unwind the multi-billion-dollar deal, the Wall Street Journal reported on Thursday.
The FTC’s Unholy Antitrust Grail - WSJ
WebApr 3, 2024 · The US Federal Trade Commission (FTC) on Monday ordered Illumina to divest cancer diagnostics developer Grail, arguing that the $7.1-billion acquisition would stifle competition and innovation in the US cancer test market. WebMar 31, 2024 · Illumina founded Grail in 2016 and owns 15% of the company. The deal to acquire the rest, which was unveiled in mid-September, was particularly noteworthy because Grail was backed by Amazon (... csumb business advisor
Home - GRAIL
WebApr 4, 2024 · Grail’s blood test, called Galleri, screens for 50 types of cancer from a single blood draw. Grail is ahead of a pack of companies racing to bring similar multi-cancer detection tests to market. Illumina maintains it has the resources to drive reimbursement and broader adoption for the Grail test, ultimately saving more lives. WebAug 19, 2024 · Illumina said it wrapped up the $7.1 billion acquisition of life-sciences firm Grail, despite a legal battle with the Federal Trade Commission and antitrust concerns in … early voting in greenwood indiana